Repeated Dexmedetomidine Infusion is a Two-shot Weapon for Pain and Pain-induced Mood Disorders in Chronic Pain Patients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- The extent of reduction of consumed analgesics
研究概览
简要总结
Chronic pain (CP) was defined as pain experienced daily or on most days and induced restriction of at least one activity. CP is one of the commonest complaints confronted in outpatient clinics and constitutes a challenge for all medical provisions. CP is a multifaceted condition; postoperative CP is frequently encountered in clinical practice and may be of debilitating severity leading to worse quality of life (QOL) especially CP with a neuropathic component as post-mastectomy pain syndrome and post-amputation pain and chronic post-sternotomy pain that seriously impacts patients' QOL and affects patient recovery till 12 months after cardiac surgery. Chronic musculoskeletal pain as defined by the International Pain Association is the persistent or recurrent pain involving spine, bones, joints, and/or musculo-soft tissue.
Chronic pain was considered as a long-lasting stressor that might induce disordered mood varying between depression and anxiety with consequent challenge of this combination on treatment outcomes and consumption of health resources. This necessitated psychological screening of CP patient to identify and manage patients with disordered mood to improve CP treatment outcomes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 30 Years 至 70 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with multiple-level spinal canal stenosis who refused surgical management.
排除标准
- •Patients with other causes for CP;
- •maintained on opioid analgesia;
- •had cardiac lesions;
- •maintained on antihypertensive therapy;
- •hepatic impairment;
- •Patients can't attend the clinic to complete the course of Dexmedetomidine infusion sessions.
研究组 & 干预措施
Intervention Group
干预措施: Dexmedetomidine in 0.9 % NaCl 20 Mcg/5 mL (4 Mcg/mL) INTRAVEN SYRINGE (ML) (Drug)
Control Group
干预措施: normal saline (Drug)
结局指标
主要结局
The extent of reduction of consumed analgesics
时间窗: 6 months
Necessity of Dexmedetomidine infusion as management procedure to the chronic pain patients
次要结局
未报告次要终点
研究者
Salsabil Sayed Abdelkader
Clinical lecturer at Department of Anesthesia, Pain & ICU, Faculty of Medicine
Benha University
